Medical Oncology

, Volume 19, Issue 4, pp 267–272 | Cite as

A study of bacteremia in febrile neutropenic patients at a tertiary-care hospital with special reference to anaerobes

  • P. Mathur
  • R. Chaudhry
  • L. Kumar
  • A. Kapil
  • B. Dhawan
Original Article


Patients with hematological malignancies who are receiving chemotherapy suffer prolonged periods of neutropenia, which leads to a greater risk of infection and mortality. A prospective study was conduced to determine the incidence of bacteremia in patients of hematological malignancies over a 2-yr period. A total of 119 episodes of febrile neutropenia occurred among 96 consecutive patients, of which 35 episodes were associated with bacteremia. Forty-four percent of the isolated bacteria were Gram-positive aerobes and 46% were Gram-negative aerobes. Staphylococcus aureus, Enterococcus spp., and Escherichia coli were the most common isolates. Gram-negative bacteremia was associated with a higher mortality. Anaerobes accounted for 4.4% of all isolates. The episodes of anaerobic bacteremia were polymicrobial and had a fatal outcome. A high incidence of antimicrobial resistance among aerobic and anaerobic bacteria was also recorded. Compared to previous years, a shift from a predominating Gram-negative to a Gram-positive etiology was noted. The initial empiric antibiotic regimens should be based on a local knowledge of the most common causative microorganisms, their sensitivity pattern, and the outcome of bacteremia.

Key Words

Bacteremia febrile neutropenia hematological malignancies anaerobes antimicrobial resistance 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rubio, M., et al. (1994). Predominance of Gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect. Control Hosp. Epidemiol. 15, 101–104.PubMedCrossRefGoogle Scholar
  2. 2.
    Rolston, K.V. and Bodey, G.P. (1995). Infections in patients with cancer, in Cancer Medicine, 4th ed. (Holland, J.F., Bast, R.C., Morton, D.L., Frei, E., Kufe, D.W. and Weichselbaum, R.R., eds), pp. 3303–3333. Williams and Wilkins, Baltimore.Google Scholar
  3. 3.
    Freifeld, A.G., Walsh, T.J. and Philip, A. (1997). Infections in the cancer patient, in Cancer. Principles and Practice of Oncology, 5th ed. (DeVita, V.T., Jr, Hellman, S. and Rosenberg, S.A. eds), pp. 2659–2704, Lippincott-Raven New York.Google Scholar
  4. 4.
    Collee, J.G., Miles, R.S. and Watt, B. (1996). Tests for the identification of bacteria, in Mackie and McCartney. Practical Medical Microbiology. 14th ed. (Collee, J.G., Fraser, A.G., Marmion, B.P. and Simmons, A., eds), pp. 131–145, Churchill Livingstone, New York.Google Scholar
  5. 5.
    Forbes, B.A., Sahm, D.F. and Weissfeld, A.S. (1998). Bailey and Scott’s Diagnostic Microbiology, 10th ed. (Baron, E.J., Peterson, L.R., and Feingold, S.M., eds.), Mosby, St. Louis, MO.Google Scholar
  6. 6.
    Sutter, V.L., Citron, D.M., Finegold, S.M., et al. (1985). Wadworth Anaerobic Bacteriology Manual, 4th ed., Los Angeles, California.Google Scholar
  7. 7.
    Willis, A.T. (1960). Anaerobic Bacteriology in Clinical Medicine, Butterworth, London.Google Scholar
  8. 8.
    Miles, R.S. and Amyes, S.G.B. (1996). Laboratory control of antimicrobial therapy, in Mackie and McCartney. Practical Medical Microbiology, 14th ed. (Colle, J.G., Fraser, A.G., Marmion, B.P., and Simmons, A. eds), pp. 151–177, Churchill Livingstone, New York.Google Scholar
  9. 9.
    Johansson, P.J.H., Sternby, E. and Ursing, B. (1992). Septicemia in granulocytopenic patients: a shift in bacterial etiology. Scand. J. Infect. Dis. 24, 357–360.PubMedGoogle Scholar
  10. 10.
    Engervall, P. and Bjorkholm, M. (1995). Infections in neutropenic patients I: aetiology. Med. Oncol. 12, 251–256.PubMedCrossRefGoogle Scholar
  11. 11.
    Kasthuri, A.S., et al. (1990). A clinical study of adult leukaemias. J. Assoc. Physicians India 38(6), 403–406.PubMedGoogle Scholar
  12. 12.
    Kumar, L., Kochupillai, V. and Bhujwala, R.A. (1992). Infections in acute myeloid leukemia: study of 184 febrile episodes. J. Assoc. Physicians India 40(1), 18–20.PubMedGoogle Scholar
  13. 13.
    Aquino, V.M., Pappo, A., Buchanan, G.R., Tkaczewski, I. and Mustafa, M.M. (1995). The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr. Infect. Dis. J. 14, 140–143.PubMedCrossRefGoogle Scholar
  14. 14.
    Suppola, J.P., Kuikka, A., Vaara, M. and Valtonen, V.V. (1998). Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteremia. Scand. J. Infect. Dis. 30(2), 153–158.PubMedCrossRefGoogle Scholar
  15. 15.
    Goldstein, E.J.C. (1996). Anaerobic bacteremia. Clin. Infect. Dis. 23(Suppl. 1), S97-S101.PubMedGoogle Scholar
  16. 16.
    Finegold, S.M. and Wexler, H.M. (1996). Present status of therapy for anaerobic infections. Clin. Infect. Dis. 23(Suppl. 1), S9-S14.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2001

Authors and Affiliations

  • P. Mathur
    • 1
  • R. Chaudhry
    • 1
  • L. Kumar
    • 2
  • A. Kapil
    • 1
  • B. Dhawan
    • 1
  1. 1.Department of MicrobiologyAll India Institute of Medical SciencesNew DelhiIndia
  2. 2.Department of Medical OncologyAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations